U.S. Senate Committee on Appropriations: Amyloidosis Language
HOUSE APPROPRIATIONS COMMITTEE
FISCAL YEAR 2022 LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION
AMYLOIDOSIS
REPORT LANGUAGE
H. Rpt. 117-96 (accompany H.R. 4502)
July 19, 2021
TITLE II—DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
OFFICE OF THE DIRECTOR (OD)
Amyloidosis.—The Committee directs NIH to continue its expansion of research efforts in amyloidosis, a group of rare diseases characterized by abnormally folded protein deposits in tissues. Amyloidosis is often fatal, and there is no known cure. Current methods of treatment are risky and unsuitable for many patients. Average survival without treatment is in months. The Committee directs NIH to provide an update in the fiscal year 2023 Congressional Budget Justification on the steps NIH has taken to expand research into the causes of amyloidosis and the measures taken to improve the diagnosis and treatment of this devastating group of diseases.